Trockene altersabh?ngige Makuladegeneration

详细信息    查看全文

• 作者：Dr. C.N. von Strachwitz (1)
  
• 关键词：Genetische Risikofaktoren ; Komplementsystem ; ARMS2/HTRA1 ; Umweltbedingte Risikofaktoren ; Ma?geschneiderte Therapie ; Genetic risk factors ; Complement system ; ARMS2/HTRA1 ; Environmental risk factors ; Individual therapy
• 刊名：Der Ophthalmologe
• 出版年：2013
• 出版时间：June 2013
• 年：2013
• 卷：110
• 期：6
• 页码：555-567
• 全文大小：993KB
• 参考文献：1. Friedman DS, O’Colmain BJ, Munoz B et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564-72 CrossRef
  2. Rudnicka AR, Jarrar Z, Wormald R et al (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119:571-80 CrossRef
  3. Seddon JM, Cote J, Page WF et al (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123:321-27 CrossRef
  4. Evans JR (2006) Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev:CD000254
  5. Thakkinstian A, Han P, McEvoy M et al (2006) Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 15:2784-790 CrossRef
  6. Fritsche LG, Lauer N, Hartmann A et al (2010) An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum Mol Genet 19:4694-704 CrossRef
  7. Fritsche LG, Loenhardt T, Janssen A et al (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 40:892-96 CrossRef
  8. Rivera A, Fisher SA, Fritsche LG et al (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14:3227-236 CrossRef
  9. Thornton J, Edwards R, Mitchell P et al (2005) Smoking and age-related macular degeneration: a review of association. Eye (Lond) 19:935-44
  10. Hammond BR Jr, Ciulla TA, Snodderly DM (2002) Macular pigment density is reduced in obese subjects. Invest Ophthalmol Vis Sci 43:47-0
  11. Feeney-Burns L, Ellersieck MR (1985) Age-related changes in the ultrastructure of Bruch’s membrane. Am J Ophthalmol 100:686-97
  12. Sarks JP, Sarks SH, Killingsworth MC (1994) Evolution of soft drusen in age-related macular degeneration. Eye (Lond) 8(Pt 3):269-83
  13. Sarks JP, Sarks SH, Killingsworth MC (1988) Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) 2(Pt 5):552-77
  14. Mullins RF, Russell SR, Anderson DH et al (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14:835-46
  15. Arnold JJ, Sarks SH, Killingsworth MC et al (1995) Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 15:183-91 CrossRef
  16. Boulton M, Docchio F, Dayhaw-Barker P et al (1990) Age-related changes in the morphology, absorption and fluorescence of melanosomes and lipofuscin granules of the retinal pigment epithelium. Vision Res 30:1291-303 CrossRef
  17. Zhou J, Kim SR, Westlund BS et al (2009) Complement activation by bisretinoid constituents of RPE lipofuscin. Invest Ophthalmol Vis Sci 50:1392-399 CrossRef
  18. Curcio CA (2001) Photoreceptor topography in ageing and age-related maculopathy. Eye (Lond) 15:376-83
  19. Anderson DH, Fisher SK, Erickson PA et al (1980) Rod and cone disc shedding in the rhesus monkey retina: a quantitative study. Exp Eye Res 30:559-74 CrossRef
  20. Delori FC, Dorey CK, Staurenghi G et al (1995) In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 36:718-29
  21. Fleckenstein M, Schmitz-Valckenberg S, Adrion C et al (2010) Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration. Invest Ophthalmol Vis Sci 51:3846-852 CrossRef
  
• 作者单位：Dr. C.N. von Strachwitz (1)
  
  1. AugenCentrum Südwest, Hauptstr. 4, 70563, Stuttgart, Deutschland
  
• ISSN：1433-0423

文摘

Atrophic age-related macular degeneration (AMD) is a degenerative disorder of the central retina that greatly increases with age. This complex disease is mainly based on a genetic background but environmental factors are most likely responsible for modulating the individual course of the disorder. Various mechanisms are thought to underlie this chronic disorder. Besides defective inflammatory control pathways, increased susceptibility to oxidative stress and defective clearing mechanisms of waste products, primary atrophy of photoreceptors and choroidal capillaries may also lead to the typical clinical signs and symptoms of AMD. Therapeutic approaches therefore aim at modulation of the different disease pathways which probably differ from individual to individual. In the future customized therapeutic strategies are expected to be of great value to slow down disease progression or even prevent outbreak of the disorder.